4-[(2-Amino-4-hydroxypyrimido [5,4-d] pyrimidin-6-ylmethyl)amino] benzoic acid (3) and its 2-hydroxy analog (4), in which C7 and Ns of the pteridine nucleus are interchanged, were synthesized in seven steps from 5-bromo-2-hydroxymethyl-4-pyrimidinecarboxylic acid. Efforts to condense p-carbethoxyanilinoacetamidine hydrochloride (6) with mucobromic acid did not succeed.Many chemically modified analogs of pteroylglutamic acid (2) and pteroic acid (1) are known to antagonize the growth-promoting activity of the vitamin 2 which is known to function in its tetrahydro form.3Recent interest in this field has been centered on the preparation and biochemical study of deazapteridine analogs in efforts to determine the structural requirements for the biological activity.4 No attempt has heretofore been made, however, to investigate the effect on the activity of changing the relative positions of the nitrogen atoms in the pteridine nucleus.We have been particularly interested in an isomer in which C7 and Ns of the pteridine ring of pteroic acid are interchanged. This paper describes the synthesis of 3, in which this interchange has been accomplished.An initial approach to this synthesis involved the preparation of 2-amino-6-methylpyrimido [5,4-d]pyrimidin-4-ol and unsuccessful efforts to attach p-aminobenzoic acid at the 6-methyl site.5 It seemed more promising, therefore, to prepare first a pyrimidine ring with the desired side chain followed by construction of the second pyrimidine ring. Accordingly, condensation of p-carbethoxyanilinoacetamidine hydrochloride (6) with mucobromic acid was attempted. Then the (1) (a) This investigation was supported by Public Health Service Research Grant CA-05781 from the National Cancer Institute, for which a grateful acknowledgment is expressed, (b) Abstracted in part from a thesis submitted by D. . K. to the University of North Carolina in partial fulfillment of requirements for the Ph.D. degree, 1965.